New U.S. Guidelines Recommend Self-Testing for HPV in Cervical Cancer Screening

Women aged 30 to 65 can now collect their own samples for HPV testing in clinical settings, offering an alternative to traditional Pap smears.

The U.S. Preventive Services Task Force has proposed updated guidelines allowing women aged 30 to 65 to self-collect vaginal samples for HPV testing in clinical settings every five years.
The new self-testing option aims to increase cervical cancer screening rates, particularly among women who may avoid traditional Pap smears due to discomfort or access issues.
Studies show HPV testing is more effective at detecting cervical cancer in women over 30 than Pap smears, though both methods remain available under the guidelines.
Cervical cancer cases and deaths have significantly declined due to widespread screening and HPV vaccination, but disparities persist, with higher rates among low-income women and women of color.
The draft recommendations are open for public comment until January 13, with the goal of finalizing guidelines that improve accessibility and equity in cervical cancer prevention.